PMID- 25572047 OWN - NLM STAT- MEDLINE DCOM- 20160218 LR - 20181113 IS - 1433-2965 (Electronic) IS - 0937-941X (Linking) VI - 26 IP - 4 DP - 2015 Apr TI - Cost-effectiveness of hip protector use on a geriatric ward in Germany: a Markov model. PG - 1367-79 LID - 10.1007/s00198-014-3008-7 [doi] AB - In this study, we determined the cost-effectiveness of hip protector use compared with no hip protector on a geriatric ward in Germany. From both the societal and the statutory health insurance (SHI) perspectives, the cost-effectiveness ratios for the provision of hip protectors were below 12,000/quality-adjusted life year (QALY) even if unrelated costs in added life years were included. INTRODUCTION: The aim of this study is to determine the cost-effectiveness of the provision of hip protectors compared with no hip protectors on a geriatric ward in Germany. METHODS: A lifetime decision-analytic Markov model was developed. Costs were measured from the societal and from the statutory health insurance (SHI) perspectives and comprised direct medical, non-medical and unrelated costs in additional life years gained. Health outcomes were measured in terms of quality-adjusted life years (QALYs). To reflect several levels of uncertainty, first- and second-order Monte Carlo simulation (MCS) approaches were applied. RESULTS: Hip protector use compared with no hip protector results in savings (costs, -5.1/QALYs, 0.003) for the societal perspective. For the SHI perspective, the incremental cost-effectiveness ratio was 4416 /QALY (costs, +13.4). If unrelated costs in life years gained were included, the cost-effectiveness ratio increases to 9794/QALY for the societal perspective and to 11,426/QALY for the SHI perspective. In the MCS, for the societal perspective without unrelated costs, 47 % of simulations indicated hip protectors to be cost saving (i.e. lower costs and higher effects). CONCLUSION: Although the gain in QALYs due to the provision of providing hip protectors to patients on geriatric wards is small, all scenarios showed acceptable cost-effectiveness ratios or even savings. FAU - Stollenwerk, B AU - Stollenwerk B AD - Helmholtz Zentrum Munchen, German Research Center for Environmental Health, Institute of Health Economics and Health Care Management, Ingolstadter Landstrasse 1, 85764, Neuherberg, Germany, bjoern.stollenwerk@helmholtz-muenchen.de. FAU - Bartmus, T AU - Bartmus T FAU - Klug, F AU - Klug F FAU - Stock, S AU - Stock S FAU - Muller, D AU - Muller D LA - eng PT - Journal Article DEP - 20150109 PL - England TA - Osteoporos Int JT - Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA JID - 9100105 SB - IM MH - Aged MH - Aged, 80 and over MH - Cost-Benefit Analysis MH - Decision Support Techniques MH - Female MH - Germany MH - Health Care Costs/*statistics & numerical data MH - Health Services Research/methods MH - Hip Fractures/*economics/*prevention & control MH - Humans MH - Male MH - Markov Chains MH - *Models, Econometric MH - Patients' Rooms/*economics MH - Protective Devices/*economics MH - Quality-Adjusted Life Years MH - Sensitivity and Specificity EDAT- 2015/01/13 06:00 MHDA- 2016/02/19 06:00 CRDT- 2015/01/10 06:00 PHST- 2014/06/16 00:00 [received] PHST- 2014/12/15 00:00 [accepted] PHST- 2015/01/10 06:00 [entrez] PHST- 2015/01/13 06:00 [pubmed] PHST- 2016/02/19 06:00 [medline] AID - 10.1007/s00198-014-3008-7 [doi] PST - ppublish SO - Osteoporos Int. 2015 Apr;26(4):1367-79. doi: 10.1007/s00198-014-3008-7. Epub 2015 Jan 9.